DiscoveryBioMed
Business Services · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
219 Kingsmill Dr, Advance, North Carolin...Phone Number
(205) 918-8138Website
www.discoverybiomed.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About DiscoveryBioMed
About DiscoveryBioMed, Inc. is in its 13th year of operation as a life sciences and biotechnology company focused on leveraging normal and diseased human cell platform technologies for its CRO services business and for its R&D programs. DBM is located in Birmingham, AL where it is leading an effort to build a critical mass of biotechnology companies in a new hub of the Deep South. The Monell Chemical Senses Center is an independent nonprofit basic research institute based in Philadelphia, Pennsylvania. Founded in 1968, Monell's mission is to improve health and well-being by advancing the scientific understanding of taste, smell, and related senses, where discoveries aid improving nutritional health, diagnosing and treating disease, addressing smell and taste loss, and digitizing chemosensory data.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DiscoveryBioMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if DiscoveryBioMed had a recent Job posting/layoffs
DiscoveryBioMed, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on DiscoveryBioMed recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at DiscoveryBioMed
Funding: Get notified immidiatlly once DiscoveryBioMed has new funding data
Website visits: Recent activity has been detected on your website
Check if DiscoveryBioMed has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when DiscoveryBioMed launches new products
Check out if DiscoveryBioMed is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
DiscoveryBioMed is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DiscoveryBioMed is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DiscoveryBioMed.
DiscoveryBioMed Tech Stack
A closer look at the technologies used by DiscoveryBioMed
DiscoveryBioMed News & Media
TumorCube, a New Unit within DiscoveryBioMed, Will Use 3D Biogel-based Platforms to Perform 384-Well Plate-based Bioassays and 3D Bioreactor-driven Studies to Discover, Validate and Profile Anti-cancer Therapeutics on Human Cancer Cells
BIRMINGHAM, Ala.--(BUSINESS WIRE)--DiscoveryBioMed, Inc. (DBM, www.discoverybiomed.com) announces a new unit of its contract research organization (CRO) services business called TumorCube that is formed based upon our growing expertise in 3D Biogel-driven bioassays on diseased and normal human cell platform technologies. A trademark application has been filed. “DBM has a growing CRO services business in 3D Biogel-driven bioassays of diseased and normal human kidney cells. It is showcased prominSENTIRIX, a New DiscoveryBioMed Unit Working With Monell Center Licensed Technology, Will Implement Human Taste Bud Cell Platform Technologies as a Valuable Screening and Profiling Tool for the Food, Beverage, Flavor & BioPharmaceutical Marketplaces
BIRMINGHAM, Ala.--(BUSINESS WIRE)--DiscoveryBioMed, Inc. (DBM, www.discoverybiomed.com) announces a new unit of its contract research organization (CRO) services business called Sentirix formed based upon our continuing 5-year collaboration with world-renowned, Philadelphia-based Monell Chemical Senses Center. “The name, Sentirix, is derived from the Latin word sentire ‘to feel in a sensory way,’” explained Dr. Erik Schwiebert, Ph.D., CEO of DBM. “Our logo showcases the name and illustrates a tDiscoveryBioMed and Monell Chemical Senses Center Awarded $1.68 Million Small Business Grant to Profile Bitter Taste Blockers
BIRMINGHAM, Ala.--(BUSINESS WIRE)--DiscoveryBioMed, Inc. (DBM) has been awarded nearly $1.7 million over the next two years by the National Institutes of Health’s Small Business Technology Transfer Research (STTR) program to find bitter taste blockers to improve medication compliance. This STTR award is administered by the National Institute on Deafness and Other Communication Disorders (NIDCD) within the National Institutes of Health. Philadelphia-based Monell Chemical Senses Center is a long-
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DiscoveryBioMed
Sign Up For FreeTo access detailed company insights
About DiscoveryBioMed, Inc. is in its 13th year of operation as a life sciences and biotechnology company focused on leveraging normal and diseased human cell platform technologies for its CRO services business and for its R&D programs. DBM is located in Birmingham, AL where it is leading an effort to build a critical mass of biotechnology companie... Read More
